USNA
USANA HEALTH SCIENCES INC
-0.26 (-1.77%)14.45USD49.1K成交股數267M市值–本益比(近四季)0.3股價營收比-5.3%營收年增(近四季)2026-10-21下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 1 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q2 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 223M-5% | 250M+0% | 226M+13% | 214M+0% | 236M+4% | 250M+13% | 200M-6% | 213M-11% | 228M | 221M | 213M | 238M |
| 營業成本 | 48.3M | 59.4M | 49.4M | 48.8M | 50.2M | 52.4M | 39.3M | 40.3M | 43.1M | 42.3M | 42.5M | 43.3M |
| 毛利 | 175M-6% | 191M-3% | 177M+10% | 165M-4% | 186M+1% | 197M+10% | 161M-6% | 173M-11% | 185M | 179M | 171M | 195M |
| 毛利率 | 78.3% | 76.2% | 78.2% | 77.2% | 78.7% | 79.0% | 80.4% | 81.1% | 81.1% | 80.9% | 80.1% | 81.8% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 82.3M | 88.3M | 78.1M | 85.9M | 81.9M | 91.4M | 61.3M | 64.3M | 64.3M | 58.7M | 63.3M | 68.1M |
| 營業利益 | −20.0M-220% | 13.9M-11% | 3.8M-76% | 1.2M-93% | 16.7M-32% | 15.7M-35% | 15.6M-11% | 17.8M-27% | 24.7M | 24.2M | 17.6M | 24.4M |
| 營業利益率 | -9.0% | 5.5% | 1.7% | 0.6% | 7.1% | 6.3% | 7.8% | 8.4% | 10.8% | 11.0% | 8.3% | 10.2% |
| 稅後淨利 | −21.4M-321% | 7.5M-20% | −1.8M-117% | −6.5M-163% | 9.7M-42% | 9.4M-44% | 10.6M-7% | 10.4M-40% | 16.5M | 16.8M | 11.3M | 17.3M |
| 淨利率 | -9.6% | 3.0% | -0.8% | -3.1% | 4.1% | 3.8% | 5.3% | 4.9% | 7.3% | 7.6% | 5.3% | 7.3% |
| 稀釋 EPS | -1.16-323% | 0.41-16% | -0.07-113% | -0.36-167% | 0.52-40% | 0.49-44% | 0.56-5% | 0.54-39% | 0.86 | 0.87 | 0.59 | 0.89 |
| 稀釋股數 | 18.5M | 18.4M | 18.6M | 18.3M | 18.5M | 19.1M | 19.1M | 19.2M | 19.3M | 19.3M | 19.4M | 19.4M |
資產負債表 期末餘額
| 科目 | 27Q2 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 169M | 163M | 158M | 145M | 151M | 180M | 365M | 332M | 328M | 330M | 307M | 300M |
| 應收帳款 | 3.3M | 9.7M | 4.3M | – | – | – | – | – | – | – | – | – |
| 存貨 | 86.3M | 96.4M | 103M | 90.8M | 83.3M | 73.6M | 64.0M | 61.8M | 60.9M | 61.5M | 60.1M | 62.0M |
| 總資產 | 703M | 739M | 743M | 727M | 735M | 747M | 671M | 631M | 629M | 633M | 601M | 603M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 132M | 144M | 157M | 145M | 149M | 163M | – | – | – | 136M | – | – |
| 股東權益 | 526M | 544M | 533M | 528M | 531M | 530M | 533M | 512M | 500M | 497M | 470M | 469M |
| 負債比 | 18.8% | 19.5% | 21.1% | 20.0% | 20.3% | 21.8% | – | – | – | 21.4% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q2 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 9.8M-37% | – | – | – | 15.5M | – | – | 17.7M | – | – | – |
| 資本支出 | – | 2.6M | – | – | – | 2.8M | – | – | 3.2M | – | – | – |
| 自由現金流 | – | 7.1M-44% | – | – | – | 12.7M | – | – | 14.5M | – | – | – |
| 折舊攤銷 | 7.7M | 8.3M | 8.6M | 7.9M | 7.7M | 8.3M | 3.6M | 3.8M | 3.2M | – | – | – |
| 買回庫藏股 | – | 0.00 | – | – | – | 12.3M | – | – | 9.4M | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 2.8% | – | – | – | 5.1% | – | – | 6.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 925M
| Core Nutritional | 775M | 83.8% | -8.3% |
|---|---|---|---|
| Hiya | 132M | 14.3% | +6599.0% |
| All Other | 17.8M | 1.9% | +164.4% |
地區2025 年度 · 878M
| 中國 | 382M | 43.5% | -7.7% |
|---|---|---|---|
| 美國 | 225M | 25.6% | +145.0% |
| Southeast Asia Pacific | 132M | 15.0% | -10.1% |
| North Asia | 70.6M | 8.0% | -9.7% |
| 韓國 | 68.9M | 7.8% | -9.9% |
| 亞太 小計 | 627M | 71.4% | -8.2% |
| Greater China 小計 | 425M | 48.3% | -7.3% |
| Americas And Europe 小計 | 298M | 33.9% | +73.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 925M | +8.3% | 10.8M | 1.2% | 0.58 | 8.5M |
| FY2025 | 855M | -7.2% | 42.0M | 4.9% | 2.19 | 50.9M |
| FY2024 | 921M | -7.8% | 63.8M | 6.9% | 3.30 | 56.1M |
| FY2023 | 999M | -15.8% | 69.4M | 6.9% | 3.59 | 93.5M |
| FY2022 | 1.2B | +4.6% | 117M | 9.8% | 5.73 | 108M |
| FY2021 | 1.1B | +7.0% | 125M | 11.0% | 5.86 | 145M |
| FY2020 | 1.1B | -10.8% | 101M | 9.5% | 4.41 | 110M |
| FY2019 | 1.2B | – | 126M | 10.6% | 5.12 | 141M |